With the advent of low background uptake in the normal brain tissue and a high tumor-to-brain ratio of 68Ga-PSMA and a theranostic pair of 177Lu-PSMA, recent efforts have been made to exploit this mechanism for treatment, showing good imaging characteristics but a limited use of 177Lu-PSMA (24). This evidence concerns the gene FOLH1 and neoplasm.